Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Expert Opin Drug Saf. 2017 May 19;16(6):651–672. doi: 10.1080/14740338.2017.1325869

Table 3.

Summary of innate and adaptive immune evasion by hepatitis C virus (HCV) infection and hepatitis B virus (HBV) infection.

Innate immune evasion Adaptive immune evasion
HCV
  • RIG-I and TLR3 signaling leading to induction of type I IFNs and proinflammatory cytokines

  • Induction of interferon stimulated genes

    • Exhaustion of type I IFN signalling

  • NS3/4a cleavage of RIG-I and TLR3 adapter proteins

  • HCV core, NS5a and E2 protein interference with JAK-STAT signaling

  • NK cell dysfunction with polarization towards cytotoxicity and impaired IFN-γ production

  • CD4 T cell depletion early during infection, with weak or absent CD4 T cell responses

  • Chronic antigenic stimulation leading to CD8 T cell failure characterized by weak responses, lack of proliferation, exhaustion and selection for escape mutants

  • Selection for neutralizing antibody escape variants (limited effect)

HBV
  • Weak innate immune responses

  • NK cell dysfunction with polarization towards cytotoxicity and impaired IFN-γ production

  • CD4 T cell depletion early during infection, with weak or absent CD4 T cell responses

  • CD8 T cell failure characterized by non-specific responses, exhaustion and deletion

  • Reduced CD4 T helper 2 cells required for B cell expansion

  • Down regulation of co-stimulatory molecules on B cells

  • Functional impairment of B cells

RIG-I = Retinoic acid-inducible gene I

TLR = Toll-like receptor

IFN = Interferon

NK = Natural killer